Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YF476 added to amoxicillin + clarithromycin for H. pylori eradication in healthy carriers
2007-002137-37Phase 2Completed
- Sponsor
- Trio Medicines Ltd
- Start
- May 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of netazepide in Helicobacter pylori infection (2 arms), sponsored by Trio Medicines Ltd. Primary endpoint: H. pylori eradication by breath test. Started May 2007; status: completed.
02
Drugs
netazepide
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2007-002137-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002137-37.